Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Selectis Health ( (GBCS) ) has issued an update.
Effective January 1, 2026, Selectis Health, Inc. appointed Kent J. Lund and former CEO Lance Baller to its Board of Directors, signaling a strategic move to deepen the board’s expertise in legal, compliance, and capital markets. Lund, a veteran business, legal, and securities professional with a background spanning federal appellate clerkship, private legal practice, in-house corporate counsel roles, and senior compliance positions at broker-dealers and registered investment advisers, adds significant regulatory and governance experience. Baller, who previously led Selectis Health from 2015 to 2023 and has founded, managed, and exited numerous businesses across mining, specialty chemicals, investment management, and infrastructure, brings extensive corporate finance, M&A, and restructuring experience, as well as ongoing board and audit committee leadership in multiple organizations, positioning Selectis to navigate complex transactions and potential strategic shifts.
The most recent analyst rating on (GBCS) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Selectis Health stock, see the GBCS Stock Forecast page.
Spark’s Take on GBCS Stock
According to Spark, TipRanks’ AI Analyst, GBCS is a Underperform.
The overall stock score for GBCS is primarily impacted by its weak financial performance, characterized by negative profitability and high leverage. Technical analysis indicates bearish momentum, and the valuation is unattractive due to a negative P/E ratio. The absence of earnings call data and corporate events does not affect the score.
To see Spark’s full report on GBCS stock, click here.
More about Selectis Health
Selectis Health, Inc., a Utah corporation, operates in the healthcare sector, though this release focuses on its corporate governance and leadership rather than its specific medical or care services. The company’s governance structure is evolving with the addition of seasoned professionals who bring extensive experience in securities law, compliance, corporate finance, and board oversight, potentially strengthening its strategic and regulatory posture in the market.
Average Trading Volume: 4,189
Technical Sentiment Signal: Hold
Current Market Cap: $6.84M
Find detailed analytics on GBCS stock on TipRanks’ Stock Analysis page.